|

L19IL2/L19TNF Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Daromun

Pipeline

Phase 2: 1

Top Sponsors

  • Philogen S.p.A.1

Indications

  • Melanoma Stage III1
  • Melanoma Stage IV1
  • Cancer1

New York, New York1 trial

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients

Memorial Sloan Kettering Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.